GH Guardant Health, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

GH [NASD]

Guardant Health, Inc.

Healthcare | Diagnostics & Research | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.83	Insider Own	6.20%	Shs Outstand	94.38M	Perf Week	0.50%
Market Cap	8.50B	Forward P/E	-	EPS next Y	-1.12	Insider Trans	-62.36%	Shs Float	89.81M	Perf Month	-2.18%
Income	-77.30M	PEG	-	EPS next Q	-0.38	Inst Own	70.80%	Short Float	3.13%	Perf Quarter	-2.88%
Sales	245.20M	P/S	34.65	EPS this Y	15.70%	Inst Trans	-10.94%	Short Ratio	2.75	Perf Half Y	9.09%
Book/sh	8.32	P/B	10.29	EPS next Y	20.60%	ROA	-8.10%	Target Price	110.00	Perf Year	-22.38%
Cash/sh	5.24	P/C	16.34	EPS next 5Y	29.30%	ROE	-9.60%	52W Range	55.90 - 112.21	Perf YTD	9.56%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-10.10%	52W High	-23.71%	Beta	-
Dividend %	-	Quick Ratio	7.10	Sales past 5Y	-	Gross Margin	68.30%	52W Low	53.15%	ATR	3.77
Employees	622	Current Ratio	7.40	Sales Q/Q	83.90%	Oper. Margin	-38.20%	RSI (14)	54.11	Volatility	5.98% 4.47%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	3.10%	Profit Margin	-31.50%	Rel Volume	2.34	Prev Close	82.75
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 06 AMC	Payout	-	Avg Volume	1.03M	Price	85.61
Recom	1.20	SMA20	2.66%	SMA50	3.07%	SMA200	9.19%	Volume	2,396,372	Change	3.46%

Jun-12-20

Initiated

BTIG Research

Buy

Feb-21-20

Initiated

Guggenheim

Buy

$103

Jan-07-20

Initiated

Citigroup

Buy

$100

Aug-07-19

Reiterated

Canaccord Genuity

Buy

$96 → $125

Apr-16-19

Initiated

Canaccord Genuity

Buy

$90

Apr-10-19

Upgrade

BofA/Merrill

Neutral → Buy

$81 → $84

Feb-28-19

Reiterated

BofA/Merrill

Neutral

$42 → $60

Oct-29-18

Initiated

William Blair

Outperform

Oct-29-18

Initiated

JP Morgan

Overweight

$42

Oct-29-18

Initiated

BofA/Merrill

Neutral

$37

Aug-07-20 02:25PM	Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers GlobeNewswire
Aug-06-20 08:30PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:07PM	Sons SoftBank Poised to Return to Profit After Big Losses Bloomberg
04:03PM	Guardant Health Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-02-20 06:46AM	3 Healthcare Stocks That Could Make You Rich Motley Fool
Jul-30-20 04:10PM	Guardant Health Announces Collaboration with Radius Health to Develop Liquid Biopsy Companion Diagnostic for Elacestrant GlobeNewswire
12:33PM	Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-26-20 07:08AM	$10,000 Invested in These Growth Stocks Could Make You a Fortune Motley Fool
Jul-22-20 11:30AM	Is Guardant Health (GH) Outperforming Other Medical Stocks This Year? Zacks
Jul-21-20 08:05AM	Guardant Health Announces Webcast of Second Quarter Financial Results on August 6, 2020 GlobeNewswire
Jul-19-20 07:03AM	Got $5,000? 3 Brilliant Stocks to Buy Right Now Motley Fool
Jul-17-20 08:00AM	How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market Investor's Business Daily
Jul-13-20 01:12PM	Why Guardant Health (GH) is an Incredible Growth Stock? Insider Monkey -5.74%
Jul-12-20 07:37PM	Did Hedge Funds Make The Right Call On Guardant Health, Inc. (GH)? Insider Monkey
Jul-08-20 12:09PM	Here's Why Guardant Health Dropped 10.2% in June Motley Fool
08:05AM	Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic GlobeNewswire
Jul-05-20 07:07AM	Buying These 3 Stocks Could Make You Crazy Rich Motley Fool
Jul-02-20 09:03AM	10 Stocks to Invest in the Health Care Revolution Kiplinger
Jun-23-20 07:55AM	Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology Drug Development GlobeNewswire
Jun-22-20 09:05AM	Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liquid Biopsy Highly Accurate in Detecting Early-Stage Colorectal Cancer GlobeNewswire +5.30%
Jun-16-20 04:30PM	Guardant Health Appoints Vijaya Gadde to its Board of Directors GlobeNewswire
Jun-14-20 07:08AM	Buying These 3 Stocks Is a Brilliant Move to Make Right Now Motley Fool
Jun-13-20 08:10AM	Could Guardant Health Be a Millionaire-Maker Stock? Motley Fool
Jun-12-20 11:42AM	Largest Insider Trades of the Week GuruFocus.com
Jun-08-20 04:03PM	Guardant Health Announces Full Exercise of Option and Closing of Public Offering GlobeNewswire
02:50PM	Hedge Funds Arent Crazy About Guardant Health, Inc. (GH) Anymore Insider Monkey
Jun-01-20 10:32PM	Guardant Health Announces Pricing of Upsized Public Offering GlobeNewswire
04:37PM	Guardant Health Announces Proposed Public Offering of Common Stock GlobeNewswire
May-29-20 04:03PM	Guardant Health to Participate in the William Blair 2020 Growth Stock Conference GlobeNewswire
May-23-20 07:45AM	Investing $5,000 in These 3 Stocks Could Make You a Fortune Over the Next 10 Years Motley Fool
May-15-20 08:05AM	Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Biopsy for Precision Oncology in Advanced and Early Stage Cancer GlobeNewswire +5.49%
May-09-20 05:01PM	Guardant Health Inc (GH) Q1 2020 Earnings Call Transcript Motley Fool
May-08-20 04:27PM	Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable' Investor's Business Daily +5.00%
10:27AM	Will Guardant Health Continue to Surge Higher? Zacks
May-07-20 04:03PM	Guardant Health Reports First Quarter 2020 Financial Results GlobeNewswire
09:51AM	Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify Zacks
May-06-20 04:03PM	Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference GlobeNewswire
09:45AM	5 Top-Ranked Stocks to Tap Earnings Beat Potential Zacks
May-05-20 08:05AM	Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for Patients with Metastatic Non-Small Cell Lung Cancer GlobeNewswire +5.36%
07:01AM	Have $1,000? Consider Investing It in 1 of These Hot Growth Stocks Motley Fool
May-02-20 10:35AM	Guardant Health Presents Data at DDW Virtual Meeting Highlighting its Early Cancer Detection Program GlobeNewswire
Apr-30-20 04:03PM	Guardant Health Announces Webcast of First Quarter Financial Results on May 7, 2020 GlobeNewswire
Apr-10-20 08:39PM	SoftBanks Problems Are Mounting. Its Next Issue Could Be Ride-Sharing Companies Like Uber. Barrons.com
Apr-09-20 08:05AM	Study Shows Guardant360 Test Identifies Predictors of Response to PIK3CA Inhibitors in Women with HR+ Metastatic Breast Cancer GlobeNewswire +6.73%
Apr-03-20 01:10PM	Insiders Roundup: NGM, Legg Mason GuruFocus.com -7.11%
Mar-25-20 05:45PM	Guardant Health (GH) Gains But Lags Market: What You Should Know Zacks
Mar-23-20 10:46AM	Hedge Funds Have Never Been This Bullish On Guardant Health, Inc. (GH) Insider Monkey -6.45%
Mar-13-20 09:22AM	Guardant Health (GH) in Focus: Stock Moves 6.5% Higher Zacks +5.57%
Feb-26-20 08:34AM	Guardant Health, Inc. Just Reported, And Analysts Assigned A US$113 Price Target Simply Wall St. +7.53%
Feb-25-20 09:32AM	Zacks.com featured highlights include: Vista Outdoor, Guardant Health, Computer Programs and Systems, MicroStrategy and Sibanye Gold Zacks -10.08%
08:58AM	Regeneron (REGN) Catches Eye: Stock Jumps 5.5% Zacks
Feb-24-20 06:05PM	Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates Zacks -5.09%
04:03PM	Guardant Health Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Outlook GlobeNewswire
08:59AM	BioMarin (BMRN) Catches Eye: Stock Jumps 6.1% Zacks
Feb-20-20 10:47AM	Guardant Health (GH) to Report Q4 Earnings: What's in Store? Zacks
Feb-19-20 05:50PM	Guardant Health (GH) Outpaces Stock Market Gains: What You Should Know Zacks
09:50AM	bluebird (BLUE) Q4 Earnings Miss Estimates, Revenues In Line Zacks
05:44AM	Bull of the Day: Guardant Health (GH) Zacks
Feb-17-20 12:30PM	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know Zacks
11:30AM	Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? Zacks
Feb-14-20 10:49AM	Alkermes' (ALKS) Earnings and Revenues Beat Estimates in Q4 Zacks
10:35AM	Cyberattack costs East Bay biotech company $20 million American City Business Journals
09:18AM	Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q4 Zacks
Feb-13-20 05:45PM	Guardant Health (GH) Dips More Than Broader Markets: What You Should Know Zacks
Feb-12-20 08:10PM	SoftBank Founder Son Says Hes Open to Working With Elliott Bloomberg +5.26%
06:15PM	Guardant Health to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-11-20 09:22AM	Trevena (TRVN) Resubmits NDA for Pain Drug Oliceridine to FDA Zacks
Feb-10-20 04:05PM	Guardant Health to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 GlobeNewswire
Feb-04-20 06:41PM	Should Growth Investors Buy this Cancer Screening Biotech Stock? Zacks
Jan-30-20 11:30AM	Has Guardant Health (GH) Outpaced Other Medical Stocks This Year? Zacks
10:15AM	Alexion (ALXN) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Jan-29-20 10:06AM	Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation Zacks
Jan-24-20 05:50PM	Guardant Health (GH) Dips More Than Broader Markets: What You Should Know Zacks
Jan-22-20 05:16PM	Steven Cohen's Point72 Piles Into Menlo Therapeutics GuruFocus.com
Jan-21-20 08:30AM	Guardant Health Appoints High-Tech-Veteran Kumud Kalia Chief Information Officer GlobeNewswire
Jan-15-20 05:50PM	Guardant Health (GH) Outpaces Stock Market Gains: What You Should Know Zacks
Jan-13-20 05:23PM	2019 Review: Top Hedge Fund Stocks vs. Guardant Health, Inc. (GH) Insider Monkey
08:30AM	Guardant Health Announces Collaboration With Amgen to Develop a Global Liquid Biopsy Companion Diagnostic for AMG 510 KRAS G12C Inhibitor GlobeNewswire
Jan-12-20 08:00PM	Guardant Health and NRG Oncology Initiate Randomized Trial to Investigate Circulating Tumor DNA Guided Adjuvant Therapy in Stage II Colon Cancer GlobeNewswire
Jan-10-20 05:00AM	Top Picks 2020- Guardant Health GH MoneyShow
Jan-01-20 10:44AM	Did Business Growth Power Guardant Health's (NASDAQ:GH) Share Price Gain of 114%? Simply Wall St.
Dec-31-19 11:05AM	Jazz Enrolls First Patient in Phase II/III Leukemia Study Zacks
11:01AM	Acceleron, Fulcrum Therapeutics Ink Deal for Pulmonary Disease Zacks
Dec-30-19 05:17PM	BeiGene Gets Approval for Lymphoma Drug Tislelizumab in China Zacks
04:05PM	Guardant Health to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-23-19 11:41AM	U.S. Consumer Spending Bolsters Economic Growth: 5 Picks Zacks
11:30AM	Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year? Zacks
Dec-19-19 01:45PM	Guardant Health Receives Expanded Medicare Coverage for Guardant360 Across the Vast Majority of Solid Tumor Cancers GlobeNewswire
Dec-18-19 12:56PM	6 Underperforming Guru Stocks GuruFocus.com
01:11AM	Small Gains Still Bring New Records Zacks
Dec-16-19 11:51PM	SoftBanks Son Makes a Pitch for Japan-Led Asia AI Superpower Bloomberg
03:44PM	Pacira's Exparel Spurs Growth, Exclusive Reliance a Concern Zacks
Dec-13-19 08:15AM	Large-Scale Study Shows Guardant360 Effectively Guides Precision Oncology Treatment in Metastatic Breast Cancer Patients GlobeNewswire
Dec-12-19 03:19PM	ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study Zacks
02:34PM	BioCryst Submits NDA for Hereditary Angioedema Candidate Zacks
Dec-11-19 10:06AM	VistaGen Up on Fast Track Designation for Anxiety Disorder Drug Zacks
08:15AM	Study Shows Only 40 Percent of Patients with Metastatic Colon Cancer Receive Guideline-Recommended Biomarker Testing GlobeNewswire
Dec-09-19 10:23AM	Guardant Health, Gap, GameStop, Microsoft and Sony highlighted as Zacks Bull and Bear of the Day Zacks
05:27AM	Bull of the Day: Guardant Health (GH) Zacks
Dec-06-19 10:02AM	Hedge Funds Have Never Been This Bullish On Guardant Health, Inc. (GH) Insider Monkey

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Talasaz AmirAli	Chairman, President and COO	Aug 04	Option Exercise	4.18	15,000	62,700	2,704,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 04	Sale	84.19	15,000	1,262,877	2,689,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 03	Option Exercise	4.18	60,000	250,800	2,749,532	Aug 05 04:55 PM
Talasaz AmirAli	Chairman, President and COO	Aug 03	Sale	86.26	60,000	5,175,768	2,689,532	Aug 05 04:55 PM
MERESMAN STANLEY J	Director	Jul 10	Option Exercise	5.94	6,000	35,640	10,059	Jul 14 05:00 PM
MERESMAN STANLEY J	Director	Jul 10	Sale	86.66	6,000	519,960	4,059	Jul 14 05:00 PM
Talasaz AmirAli	Chairman, President and COO	Jul 06	Option Exercise	4.18	20,108	84,051	2,709,640	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 06	Sale	84.10	20,108	1,691,001	2,689,532	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 02	Option Exercise	4.18	54,892	229,449	2,744,424	Jul 06 08:12 PM
Talasaz AmirAli	Chairman, President and COO	Jul 02	Sale	83.87	54,892	4,603,794	2,689,532	Jul 06 08:12 PM
CLARK IAN T	Director	Jun 25	Option Exercise	4.18	538	2,249	5,181	Jun 29 05:59 PM
CLARK IAN T	Director	Jun 25	Sale	81.27	538	43,723	4,643	Jun 29 05:59 PM
MERESMAN STANLEY J	Director	Jun 10	Option Exercise	5.94	6,000	35,640	7,302	Jun 12 05:08 PM
MERESMAN STANLEY J	Director	Jun 10	Sale	80.59	6,000	483,540	1,302	Jun 12 05:08 PM
SVF Bluebird (Cayman) Ltd	10% Owner	Jun 08	Sale	83.16	1,162,500	96,673,500	14,037,960	Jun 08 08:23 PM
SVF Bluebird (Cayman) Ltd	10% Owner	Jun 04	Sale	83.16	7,750,000	644,490,000	15,200,460	Jun 08 08:23 PM
Talasaz AmirAli	Chairman, President and COO	Jun 03	Option Exercise	4.18	55,000	229,900	2,744,532	Jun 04 04:46 PM
CLARK IAN T	Director	Jun 03	Option Exercise	4.18	2,690	11,244	3,992	Jun 05 05:03 PM
CLARK IAN T	Director	Jun 03	Sale	87.52	2,690	235,429	1,302	Jun 05 05:03 PM
Talasaz AmirAli	Chairman, President and COO	Jun 03	Sale	85.63	55,000	4,709,402	2,689,532	Jun 04 04:46 PM
Talasaz AmirAli	Chairman, President and COO	Jun 02	Option Exercise	4.18	20,000	83,600	2,709,532	Jun 04 04:46 PM
Talasaz AmirAli	Chairman, President and COO	Jun 02	Sale	87.63	20,000	1,752,673	2,689,532	Jun 04 04:46 PM
CLARK IAN T	Director	May 26	Option Exercise	4.18	538	2,249	1,840	May 26 05:16 PM
CLARK IAN T	Director	May 26	Sale	98.50	538	52,993	1,302	May 26 05:16 PM
BERTOCCI DEREK A	Chief Financial Officer	May 22	Option Exercise	4.49	9,222	41,422	71,409	May 26 05:17 PM
BERTOCCI DEREK A	Chief Financial Officer	May 22	Sale	96.63	9,222	891,146	62,187	May 26 05:17 PM
Nishar Dipchand	Director	May 18	Sale	100.00	2	200	2,321	May 20 05:16 PM
Talasaz AmirAli	Chairman, President and COO	May 11	Option Exercise	4.18	6,000	25,080	2,889,483	May 11 06:45 PM
MERESMAN STANLEY J	Director	May 11	Option Exercise	5.94	6,500	38,610	7,802	May 13 05:00 PM
BERTOCCI DEREK A	Chief Financial Officer	May 11	Sale	92.53	21,862	2,022,891	62,187	May 12 05:02 PM
Talasaz AmirAli	Chairman, President and COO	May 11	Sale	91.68	199,951	18,332,329	2,689,532	May 11 06:45 PM
MERESMAN STANLEY J	Director	May 11	Sale	86.50	6,500	562,250	1,302	May 13 05:00 PM
Talasaz AmirAli	Chairman, President and COO	May 08	Option Exercise	4.18	750	3,135	2,908,532	May 11 06:45 PM
BERTOCCI DEREK A	Chief Financial Officer	May 08	Sale	90.40	913	82,533	84,049	May 12 05:02 PM
Talasaz AmirAli	Chairman, President and COO	May 08	Sale	90.13	25,049	2,257,641	2,883,483	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 07	Option Exercise	4.18	1,762	7,365	2,981,195	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 07	Sale	83.38	73,413	6,121,005	2,907,782	May 11 06:45 PM
Talasaz AmirAli	Chairman, President and COO	May 06	Option Exercise	4.18	2,400	10,032	3,079,433	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 06	Sale	81.24	100,000	8,123,659	2,979,433	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 05	Option Exercise	4.18	2,800	11,704	3,108,216	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 05	Sale	78.84	31,183	2,458,352	3,077,033	May 06 06:20 PM
CLARK IAN T	Director	May 04	Option Exercise	4.18	2,690	11,244	3,992	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 04	Option Exercise	4.18	13,435	56,158	3,169,387	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	May 04	Sale	73.22	63,971	4,684,096	3,105,416	May 06 06:20 PM
CLARK IAN T	Director	May 04	Sale	72.17	2,690	194,137	1,302	May 06 06:20 PM
Talasaz AmirAli	Chairman, President and COO	Apr 29	Option Exercise	4.18	1,040	4,347	3,199,303	Apr 30 06:09 PM
Wiley Michael J	Chief Legal Officer	Apr 29	Option Exercise	4.18	3,780	15,800	114,951	Apr 30 06:10 PM
Wiley Michael J	Chief Legal Officer	Apr 29	Sale	80.11	3,780	302,800	111,171	Apr 30 06:10 PM
Talasaz AmirAli	Chairman, President and COO	Apr 29	Sale	80.33	43,351	3,482,294	3,155,952	Apr 30 06:09 PM
Wiley Michael J	Chief Legal Officer	Apr 28	Option Exercise	4.18	1,220	5,100	112,391	Apr 30 06:10 PM
Talasaz AmirAli	Chairman, President and COO	Apr 28	Option Exercise	4.18	314	1,313	3,211,345	Apr 30 06:09 PM
Talasaz AmirAli	Chairman, President and COO	Apr 28	Sale	80.23	13,082	1,049,573	3,198,263	Apr 30 06:09 PM
Wiley Michael J	Chief Legal Officer	Apr 28	Sale	80.02	1,220	97,628	111,171	Apr 30 06:10 PM
CLARK IAN T	Director	Apr 27	Option Exercise	4.18	538	2,249	1,840	Apr 29 05:00 PM
CLARK IAN T	Director	Apr 27	Sale	77.50	538	41,695	1,302	Apr 29 05:00 PM
Wiley Michael J	Chief Legal Officer	Apr 23	Option Exercise	4.18	5,000	20,900	116,171	Apr 27 04:57 PM
Wiley Michael J	Chief Legal Officer	Apr 23	Sale	77.32	5,000	386,615	111,171	Apr 27 04:57 PM
Talasaz AmirAli	Chairman, President and COO	Apr 20	Option Exercise	4.18	2,729	11,407	73,789	Apr 21 05:18 PM
Talasaz AmirAli	Chairman, President and COO	Apr 20	Sale	72.56	10,270	745,235	3,139,971	Apr 21 05:18 PM
Talasaz AmirAli	Chairman, President and COO	Apr 20	Sale	72.56	2,729	198,028	71,060	Apr 21 05:18 PM
Talasaz AmirAli	Chairman, President and COO	Apr 17	Option Exercise	4.18	7,771	32,483	78,831	Apr 21 05:18 PM
Talasaz AmirAli	Chairman, President and COO	Apr 17	Sale	72.70	29,230	2,125,047	3,150,241	Apr 21 05:18 PM
Talasaz AmirAli	Chairman, President and COO	Apr 17	Sale	72.70	7,771	564,959	71,060	Apr 21 05:18 PM
Eltoukhy Helmy	Chief Executive Officer	Apr 17	Sale	70.22	15,904	1,116,739	3,174,980	Apr 21 05:17 PM
Eltoukhy Helmy	Chief Executive Officer	Apr 16	Sale	70.01	200	14,001	3,190,884	Apr 16 05:48 PM
CLARK IAN T	Director	Apr 14	Option Exercise	4.18	2,689	11,240	3,991	Apr 16 05:48 PM
Eltoukhy Helmy	Chief Executive Officer	Apr 14	Sale	70.06	2,701	189,241	3,191,084	Apr 16 05:48 PM
CLARK IAN T	Director	Apr 14	Sale	70.00	2,689	188,230	1,302	Apr 16 05:48 PM
MERESMAN STANLEY J	Director	Apr 13	Option Exercise	5.94	9,500	56,430	10,802	Apr 15 05:02 PM
MERESMAN STANLEY J	Director	Apr 13	Sale	66.62	9,500	632,890	1,302	Apr 15 05:02 PM
Talasaz AmirAli	Chairman, President and COO	Apr 02	Option Exercise	4.18	5,250	21,945	76,310	Apr 06 05:02 PM
Talasaz AmirAli	Chairman, President and COO	Apr 02	Sale	67.03	5,250	351,922	71,060	Apr 06 05:02 PM
Talasaz AmirAli	Chairman, President and COO	Apr 02	Sale	67.03	19,750	1,323,895	3,179,471	Apr 06 05:02 PM
Eltoukhy Helmy	Chief Executive Officer	Mar 31	Sale	70.73	103,103	7,292,414	3,193,785	Apr 01 04:58 PM
Eltoukhy Helmy	Chief Executive Officer	Mar 30	Sale	69.83	178,093	12,436,693	3,296,888	Apr 01 04:58 PM
CLARK IAN T	Director	Mar 25	Option Exercise	4.18	538	2,249	1,840	Mar 27 05:07 PM
CLARK IAN T	Director	Mar 25	Sale	70.00	538	37,660	1,302	Mar 27 05:07 PM
BERTOCCI DEREK A	Chief Financial Officer	Mar 24	Option Exercise	8.80	114	1,003	85,076	Mar 25 05:13 PM
BERTOCCI DEREK A	Chief Financial Officer	Mar 24	Sale	65.11	114	7,422	84,962	Mar 25 05:13 PM
BERTOCCI DEREK A	Chief Financial Officer	Mar 23	Option Exercise	4.64	19,100	88,612	104,062	Mar 25 05:13 PM
BERTOCCI DEREK A	Chief Financial Officer	Mar 23	Sale	60.65	19,100	1,158,433	84,962	Mar 25 05:13 PM
Kaul Samir	Director	Mar 04	Sale	82.38	25,000	2,059,540	87,943	Mar 06 05:52 PM
CLARK IAN T	Director	Mar 03	Option Exercise	4.18	2,690	11,244	3,992	Mar 04 05:03 PM
CLARK IAN T	Director	Mar 03	Sale	78.33	2,690	210,708	1,302	Mar 04 05:03 PM
CLARK IAN T	Director	Feb 25	Option Exercise	4.18	538	2,249	1,840	Feb 27 04:32 PM
CLARK IAN T	Director	Feb 25	Sale	80.00	538	43,040	1,302	Feb 27 04:32 PM
MERESMAN STANLEY J	Director	Feb 13	Option Exercise	5.94	2,000	11,880	3,302	Feb 18 04:33 PM
MERESMAN STANLEY J	Director	Feb 13	Sale	82.02	2,000	164,040	1,302	Feb 18 04:33 PM
CLARK IAN T	Director	Feb 03	Option Exercise	4.18	2,690	11,244	3,992	Feb 05 04:18 PM
CLARK IAN T	Director	Feb 03	Sale	76.23	2,690	205,059	1,302	Feb 05 04:18 PM
CLARK IAN T	Director	Jan 27	Option Exercise	4.18	538	2,249	1,840	Jan 29 05:23 PM
CLARK IAN T	Director	Jan 27	Sale	77.31	538	41,593	1,302	Jan 29 05:23 PM
MERESMAN STANLEY J	Director	Jan 15	Option Exercise	5.94	5,000	29,700	6,302	Jan 17 06:18 PM
MERESMAN STANLEY J	Director	Jan 15	Sale	79.55	5,000	397,750	1,302	Jan 17 06:18 PM
CLARK IAN T	Director	Jan 03	Option Exercise	4.18	2,690	11,244	3,992	Jan 07 05:54 PM
CLARK IAN T	Director	Jan 03	Sale	77.87	2,690	209,470	1,302	Jan 07 05:54 PM
CLARK IAN T	Director	Dec 26	Option Exercise	4.18	538	2,249	1,840	Dec 30 05:10 PM
CLARK IAN T	Director	Dec 26	Sale	82.69	538	44,487	1,302	Dec 30 05:10 PM
Wiley Michael J	Chief Legal Officer	Dec 23	Option Exercise	4.18	6,148	25,699	121,469	Dec 26 04:36 PM
Wiley Michael J	Chief Legal Officer	Dec 23	Sale	81.67	6,148	502,098	115,321	Dec 26 04:36 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience